Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044732 · ClinicalTrials.gov registry record · NA
Third Eye Retroscope Randomized Clinical Evaluation
A NA study, sponsored by Avantis Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
NCT01044732 is a NA study that has completed, run by Avantis Medical Systems. The registered enrollment target is 448 participants.
The verdict
NCT01044732, a NA study, has completed, sponsored by Avantis Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
Study Summary
The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colonoscope alone. Patients who participate as subjects in the study will undergo two complete colonoscopy procedures, a standard colonoscopy and a colonoscopy in which a Third Eye Retroscope is used along with the same colonoscope. Half of the patients will have the standard colonoscopy first followed by the Third Eye colonoscopy, and the other half will have the Third Eye procedure first. Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.
Interventions
- DEVICE Third Eye Retroscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044732
The ClinicalTrials.gov registry entry for NCT01044732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 448 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avantis Medical Systems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Third Eye Retroscope is the first listed.
NCT01044732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044732 about?
NCT01044732 is a clinical study titled "Third Eye Retroscope Randomized Clinical Evaluation". The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colo...
What is the current status of trial NCT01044732?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01044732?
The interventions under investigation include: Third Eye Retroscope (DEVICE).
Who is sponsoring clinical trial NCT01044732?
This trial is sponsored by Avantis Medical Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.